A variant of the gene encoding leukotriene A4 hydrolase confers ethnicity-specific risk of myocardial infarction.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Gudbjartsson, Daniel F
Magnusson, Kristinn P
Grant, Struan F A
O'Brien, Stephen J
Valdimarsson, Einar M
Matthiasson, Stefan E
Levey, Allan I
Abramson, Jerome L
Reilly, Murdach P
Wolfe, Megan L
Quyyumi, Arshed A
Topol, Eric J
Rader, Daniel J
Gulcher, Jeffrey R
MetadataShow full item record
CitationNat. Genet. 2006, 38(1):68-74
AbstractVariants of the gene ALOX5AP (also known as FLAP) encoding arachidonate 5-lipoxygenase activating protein are known to be associated with risk of myocardial infarction. Here we show that a haplotype (HapK) spanning the LTA4H gene encoding leukotriene A4 hydrolase, a protein in the same biochemical pathway as ALOX5AP, confers modest risk of myocardial infarction in an Icelandic cohort. Measurements of leukotriene B4 (LTB4) production suggest that this risk is mediated through upregulation of the leukotriene pathway. Three cohorts from the United States also show that HapK confers a modest relative risk (1.16) in European Americans, but it confers a threefold larger risk in African Americans. About 27% of the European American controls carried at least one copy of HapK, as compared with only 6% of African American controls. Our analyses indicate that HapK is very rare in Africa and that its occurrence in African Americans is due to European admixture. Interactions with other genetic or environmental risk factors that are more common in African Americans are likely to account for the greater relative risk conferred by HapK in this group.
DescriptionTo access publisher full text version of this article. Please click on the hyperlink in Additional Links field
- Genetic variation in the leukotriene pathway is associated with myocardial infarction in the Chinese population.
- Authors: Li Y, Xu X, Zhang D, Cheng W, Zhang Y, Yu B, Zhang Y
- Issue date: 2019 Jan 24
- Genetic variation in the arachidonate 5-lipoxygenase-activating protein (ALOX5AP) is associated with myocardial infarction in the German population.
- Authors: Linsel-Nitschke P, Götz A, Medack A, König IR, Bruse P, Lieb W, Mayer B, Stark K, Hengstenberg C, Fischer M, Baessler A, Ziegler A, Schunkert H, Erdmann J
- Issue date: 2008 Nov
- Confronting ethnicity-specific disease risk.
- Authors: Tang H
- Issue date: 2006 Jan
- The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke.
- Authors: Helgadottir A, Manolescu A, Thorleifsson G, Gretarsdottir S, Jonsdottir H, Thorsteinsdottir U, Samani NJ, Gudmundsson G, Grant SF, Thorgeirsson G, Sveinbjornsdottir S, Valdimarsson EM, Matthiasson SE, Johannsson H, Gudmundsdottir O, Gurney ME, Sainz J, Thorhallsdottir M, Andresdottir M, Frigge ML, Topol EJ, Kong A, Gudnason V, Hakonarson H, Gulcher JR, Stefansson K
- Issue date: 2004 Mar
- The role of ALOX5AP, LTA4H and LTB4R polymorphisms in determining baseline lung function and COPD susceptibility in UK smokers.
- Authors: Tulah AS, Parker SG, Moffatt MF, Wardlaw AJ, Connolly MJ, Sayers I
- Issue date: 2011 Dec 29